Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

151 results
Display

Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020

Oh SM, Bang J, Park SW, Lee E

Background: Domestic data on antiretroviral drug (ARV) resistance are limited, while alterations in ARV resistance are expected as the incidence of human immunodeficiency virus (HIV) infection increases. We evaluated the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The complement system in preeclampsia: a review of its activation and endothelial injury in the triad of COVID-19 infection and HIV-associated preeclampsia

David M, Naicker T

This review assesses the complement system and its activation, with the pathological features of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV) infection and preeclampsia (PE). The complement...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Economic Burden of Cancer for the First Five Years after Cancer Diagnosis in Patients with Human Immunodeficiency Virus in Korea

Jang Y, Kim T, Kim BHS, Kim JH, Seong H, Kim YJ, Park B

This study aimed to estimate the medical cost of cancer in the first five years of diagnosis and in the final six months before death in people who developed cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Classic Kaposi Sarcoma Involving the Perianal Skin

Kim T, Kim Y, Won SH, Lee J, Shin K, Kim HS, Ko HC, Kim BS, Kim MB, Bae KN

  • KMID: 2543893
  • Korean J Dermatol.
  • 2023 Jun;61(5):316-330.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Story and Implications of the Korean Health Care Facility Counseling Project on People Living with HIV

Choi JP, Lee JH, An JM, Kim J, Won N, Choi YH

In 2005, the Korea Disease Control and Prevention Agency (KDCA) launched “Health Care Facility Counseling Project on People Living with human immunodeficiency virus (HIV)” funded by the private-subsidy project for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Peer-support Mini-counseling Model to Improve Treatment in HIV-positive Pregnant Women in Kupang City, East Nusa Tenggara, Indonesia

Camellia A, Swandari P, Rahma G, Merati TP, Bakta IM, Duarsa DP

Objectives: Low adherence to antiretroviral (ARV) therapy in pregnant women with human immunodeficiency virus (HIV) increases the risk of virus transmission from mother to newborn. Increasing mothers’ knowledge and motivation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rate of and Risk Factors for Loss to Follow Up in HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study

Seong H, Choi Y, Kim M, Kim JH, Song JY, Kim SW, Kim SI, Kim YJ, Park DW, Park B, Choi BY, Choi JY

Background: Owing to antiretroviral therapy (ART), acquired immune deficiency syndrome (AIDS)-related mortality has significantly decreased. Retaining in care is an essential step for human immunodeficiency virus (HIV) care cascade. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Human Immunodeficiency Virus/Hepatitis B Virus Coinfection with Persistent Anorexia and Weight Loss as Early Clinical Symptom

Lee SH, Lee JG

Human immunodeficiency virus (HIV) infection has a very low prevalence among South Koreans and exhibits nonspecific symptoms such as fever and loss of appetite in the early stages of infection....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens

Kim J, Nam HJ, Jung YJ, Lee HJ, Kim SE, Kang SJ, Park KH, Chang HH, Kim SW, Chung EK, Kim UJ, Jung SI

Background: This study explored the relationship between integrase strand transfer inhibitor (INSTI)-based anti-retroviral agents and weight gain over time, and the risk factors for weight gain in Korean people living...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Acting Injectable Antiretroviral Agents for HIV Treatment and Prevention

Kim YS

Current oral antiretroviral agents provide highly effective treatment for patients infected with human immunodeficiency virus (HIV), and can be used as pre-exposure prophylaxis (PrEP) to prevent new HIV infections. Several...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Human Immunodeficiency Virus -triggered Hemophagocytic Lymphohistocytosis Presenting with Severe Bleeding Tendency

Kim B, Choi YW, Pai H, Kim J

Human immunodeficiency virus (HIV) is one of the less common triggers of secondary hemophagocytic lymphohistiocytosis (HLH) in which coagulation disorder is a frequent manifestation. Here, we present a case of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea

Lim DH, Jeong JY, Nam S, Choi J, Kwon HC, Yoon YB, Kim Y, Chin B

Background: Because of the very low incidence of human immunodeficiency virus (HIV) coinfection in Korea, data on hepatitis C virus (HCV)/HIV coinfection are limited. This study aimed to investigate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transcriptome Analysis Identifies Altered Biological Processes and Novel Markers in Human Immunodeficiency Virus-1 Long-Term Non-Progressors

Lee D, Yoon CH, Choi SY, Kim JE, Cho YK, Choi BS, Park J

Background: The latent reservoir of Human Immunodificiency Virus-1 (HIV-1) has been a major barrier to the complete eradication of HIV-1 and the development of HIV therapy. Longterm non-progressors (LTNPs) are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study

Kim H, Kim Y, Kang J

We aimed to evaluate the safety and effectiveness of darunavir (DRV) in the treatment of human immunodeficiency virus-1 (HIV-1) infection in Korea. From October 29, 2010, 225 eligible patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Overview of Human Immunodeficiency Virus-1 Antiretroviral Drugs: General Principles and Current Status

Shin YH, Park CM, Yoon CH

Treatment with highly active antiretroviral therapy (HAART) can prolong a patient's lifespan by disrupting pivotal steps in the replication cycle of the human immunodeficiency virus-1 (HIV-1). However, drug resistance is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of Peripheral Vestibular Impairment in Adults with Human Immunodeficiency Virus

Millar A, Joubert K, Naude A

Background and Objectives: Globally, the human immunodeficiency virus (HIV) is responsible for one of the most serious pandemics to date. The vulnerability of the vestibular system in individuals with HIV...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Misconceptions and stigma against people living with HIV/AIDS: a cross-sectional study from the 2017 Indonesia Demographic and Health Survey

Suantari D

OBJECTIVES: Data are not available in Indonesia to measure the main indicators of zero new infections, zero acquired immune deficiency syndrome (AIDS)-related deaths and zero discrimination. This study aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Associations of depression and anxiety with cardiovascular risk among people living with HIV/AIDS in Korea

Park KS, Hwang SY, Choi BY, Kim J, Kim SI, Kim WJ, Kang C

OBJECTIVES: As HIV/AIDS is becoming a chronic disease, the risk of developing cardiovascular disease (CVD) among people living with HIV/AIDS is rising. Anxiety and depression, which are common among people...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Assessment of Clinical and Radiological Parameters in Spinal Tuberculosis: Comparison between Human Immunodeficiency Virus-Positive and Human Immunodeficiency Virus-Negative Patients

Sagane SS, Patil VS, Bartakke GD, Kale KY

Study Design: Prospective comparative study. Purppse: A prospective comparative analysis of 30 patients with spinal tuberculosis (15 human immunodeficiency viruses [HIV] positive and 15 HIV negative). We compared the clinical and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trends of Cause of Death among Human Immunodeficiency Virus Patients and the Impact of Low CD4 Counts on Diagnosis to Death: a Retrospective Cohort Study

Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S

Background: Monitoring the full spectrum of causes of death among human immunodeficiency virus (HIV) patients has become increasingly important as survival improves because of highly active antiretroviral therapy. However, there...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr